Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.
Pietrasz D, Pécuchet N, Garlan F, Didelot A, Dubreuil O, Doat S, Imbert-Bismut F, Karoui M, Vaillant JC, Taly V, Laurent-Puig P, Bachet JB. Pietrasz D, et al. Among authors: doat s. Clin Cancer Res. 2017 Jan 1;23(1):116-123. doi: 10.1158/1078-0432.CCR-16-0806. Epub 2016 Dec 19. Clin Cancer Res. 2017. PMID: 27993964
Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study.
Palmieri LJ, Dubreuil O, Bachet JB, Trouilloud I, Locher C, Coriat R, Moryoussef F, Landi B, Perkins G, Hautefeuille V, Doat S. Palmieri LJ, et al. Among authors: doat s. Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101431. doi: 10.1016/j.clinre.2020.03.029. Epub 2020 May 11. Clin Res Hepatol Gastroenterol. 2021. PMID: 32409285 Free article.
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.
Pietrasz D, Wang-Renault S, Taieb J, Dahan L, Postel M, Durand-Labrunie J, Le Malicot K, Mulot C, Rinaldi Y, Phelip JM, Doat S, Blons H, de Reynies A, Bachet JB, Taly V, Laurent-Puig P. Pietrasz D, et al. Among authors: doat s. Br J Cancer. 2022 Feb;126(3):440-448. doi: 10.1038/s41416-021-01624-2. Epub 2021 Nov 22. Br J Cancer. 2022. PMID: 34811505 Free PMC article. Clinical Trial.
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Torregrosa C, Pernot S, Vaflard P, Perret A, Tournigand C, Randrian V, Doat S, Neuzillet C, Moulin V, Stouvenot M, Roth G, Darbas T, Auberger B, Godet T, Jaffrelot M, Lambert A, Dubreuil O, Gluszak C, Bernard-Tessier A, Turpin A, Palmieri LJ, Bouche O, Goujon G, Lecomte T, Sefrioui D, Locher C, Grados L, Gignoux P, Trager S, Nassif E, Saint A, Hammel P, Lecaille C, Bureau M, Perrier M, Botsen D, Bourgeois V, Taieb J, Auclin E. Torregrosa C, et al. Among authors: doat s. Int J Cancer. 2022 Dec 1;151(11):1978-1988. doi: 10.1002/ijc.34166. Epub 2022 Jul 14. Int J Cancer. 2022. PMID: 35833561
Strategy for Oligometastatic Recurrence of Cardia Adenocarcinoma: Liver Radiofrequency Ablation Associated with PIPAC Inducing Response Permitting Cytoreductive Surgery and HIPEC.
Platevoet P, Doat S, Bachet JB, Maingon P, Savier É, Vaillant JC, Pocard M. Platevoet P, et al. Among authors: doat s. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):122-126. doi: 10.1007/s13193-022-01595-7. Epub 2022 Jul 18. Indian J Surg Oncol. 2023. PMID: 37359926 Free PMC article. Review.
24 results